Skip to main content

Table 3 Perioperative Variables and Postoperative Complications of the Study Population

From: Thrombotic gene polymorphisms and postoperative outcome after coronary artery bypass graft surgery

  Study population
(n = 220)
FVL 1691 G/G
(n = 196)
FVL 1691 G/A
(n = 24)
p value* PT 20210 G/G
(n = 212)
PT 20210 G/A
(n = 8)
p value** ACE I/I & I/D
(n = 124)
ACE D/D
(n = 57)
p value***
CPB time (min) 77.5 ± 15.7 77.5 ± 15.7 77.3 ± 15.9 NS 77.5 ± 15.9 77.5 ± 9.0 NS 79.2 ± 17.5 75.2 ± 11.5 NS
Number of coronary grafts 3.0 ± 1.1 3.0 ± 1.1 3.0 ± 0.9 NS 3.0 ± 1.1 2.4 ± 0.9 NS 3.1 ± 1.1 2.9 ± 1.0 NS
Postoperative blood loss at 24 hours, mL 463.5 ± 155.1 487.1 ± 150.5 460.6 ± 155.7 NS 459.6 ± 133.6 566.9 ± 449.0 NS 448.5 ± 136.0 470.9 ± 130.5 NS
Total drainage, mL 604.3 ± 204.1 597.4 ± 191.5 660.4 ± 286.3 NS 599.6 ± 176.5 730.0 ± 587.9 NS 581.1 ± 179.8 631.9 ± 187.4 0.045
Stay in intensive care unit, hours 54.9 ± 80.4 56.6 ± 85.0 42.0 ± 9.1 NS 52.9 ± 73.4 109.6 ± 190.3 NS 56.3 ± 82.7 53.0 ± 60.4 NS
In-hospital Mortality, % 6 (2.7) 6 (3.1) 0 NS 5 (2.4) 1 (12.5) NS 3 (2.4) 2 (3.5) NS
  1. * FVL 1691G/G compared with FVL 1691 G/A polymorphism; ** PT 20210 G/G compared with PT 20210 G/A polymorphism; *** ACE I/I and ACE I/D group compared with ACE D/D polymorphism group.